Enhanced dissolution and bioavailability of gliclazide using solid dispersion techniques
Keywords:
Gliclazide, solubility, solid dispersion, pharmacokinetics, peak plasma concentration, half lifeAbstract
Gliclazide is practically insoluble in water and its bioavailability is limited by dissolution rate. To enhance the dissolution rate and bioavailability the present study was aimed to formulate solid dispersions using different water soluble polymers such as polyethylene glycol 4000 (PEG 4000), polyethylene glycol 6000 (PEG 6000) using fusion method and polyvinyl pyrrolidone K- 30 (PVP K 30) by solvent evaporation method. The interaction of gliclazide with the hydrophilic polymers was studied by Differential Scanning Calorimetry (DSC), Fourier Transformation-Infrared Spectroscopy (FTIR) and X-Ray diffraction analysis. Solid dispersions were characterized for physicochemical properties like drug content, surface morphology and dissolution studies. Various factors like type of polymer and ratio of the drug to polymer on the solubility and dissolution rate of the drug were also evaluated. Pharmacokinetic studies of optimized formulation were compared with pure drug and marketed formulation in wistar rats. The dissolution of the pure drug and solid dispersion prepared with PVP K 30 (1:1) showed 38.3 + 4.5 % and 95 + 5.2 % release respectively within 30 min. Peak plasma concentration of pure drug, solid dispersion (PVP K 30) and marketed formulation was found to be 8.76 + 2.5, 16.04 + 5.5 and 9.24 + 3.6 μg/ml respectively, from these results it was observed that there is two fold increase in peak plasma concentration compared to pure drug. Solid dispersion is an effective technique in increasing solubility, dissolution rate and bioavailability of the poorly soluble drugs.
References
Al-Kassas RS, Omaimah MN, Al-Gohary, Monirah
M, Al-Faadhel. Controlling of systemic absorption
of gliclazide through incorporation into alginate
beads. Int. J. of Pharm. 2007; 341: 230–37.
Hong S, Lee S, Lee Y, Chung S, Lee M, Shim. C.
Accelerated oral absorption of gliclazide in human
subjects from a soft gelatin capsule containing a
PEG 400 suspension of gliclazide. J. Control. Rel.
; 51:185–192.
Mutalik S, Anju P, Manoj K, Usha AN.
Enhancement of dissolution rate and bioavailability
of aceclofenac: a chitosan-based solvent change
approach. Int. J .Pharm. 2008; 350(1-2): 279-290
Kim E, Chun M, Jae-Sang Jang, In-Hwa Lee,
Kyeo-Re Lee, Hoo-Kyun Choi. .Preparation of a
solid dispersion of felodipine using a solvent
wetting method. Eur. J. of Pharma. Biopharma.
; 64:200–205.
Sapkal NP, Kilor KP, Bhusari AS, Daud.
Evaluation of some Methods for Preparing
Gliclazide- β-Cyclodextrin Inclusion Complexes.
Trop. J. of Pharma. Res. 2007; 6 (4): 833-840.
Bhanubhai NS, Haresh M, Shailesh A, Shah R,
Vijay K. Preparation and characterization of
etoricoxib-polyethylene glycol 4000 plus
polyvinylpyrrolidone K30 solid dispersions. Acta
Pharm. 2006; 56: 285–298.
Leuner C, Dressman J. Improving drug solubility
for oral delivery using solid dispersions. Eur J
Pharm Biopharm. 2000; 50: 47-60.
Palmieri GF, Cantalamessa F, Martino PD, Nasuti
C, Martelli S, Lonidamine solid dispersions: in
vitro and in vivo evaluation. Drug Dev. Ind. Pharm.
; 28: 1241–1250.
Sethia S, Squillante E. Solid dispersion of
carbamazepine in PVP K30 by conventional
solvent evaporation and supercritical methods. Int.
J. of Pharm., 2004; 272: 1–10.
Vippagunta SR, Maul KA, Tallavajhala
S, Grant DJW. Solid-state characterization of
nifedipine solid dispersions. Int. J. of Pharm.
; 236: 111-123.
Van den Mooter G, Wuyts M, Blaton
N. Physical stabilisation of amorphous
ketoconazole in solid dispersions with
polyvinylpyrrolidone K25. Euro J. Pharm. Sci.
;12: 261-269.
Lobenberg R, Kramer J, Shah VP, Amidon GL,
Dressman JB. Dissolution testing as a prognostic
tool for oral drug absorption: dissolution behavior
of glibenclamide. Pharm Res. 2000; 17: 439-444.
Ruan LP, Yu BY, Fu GM, Zhu DN. Improving
the solubility of ampelopsin by solid dispersion and
inclusion complexes. J. of Pharma. Biomed. Ana.
; 38: 457–464.
Valleri M, Mura P, Maestrelli F, Cirri M,
Ballerini R. Development and evaluation of
glyburide fast dissolving tablets using solid
dispersion technique. Drug. Dev. Ind. Pharm. 2004;
: 525-534.
Damian F, Blaton N, Naesens
L. Physicochemical characterization of solid
dispersions of the antiviral agent UC-781 with
polyethylene glycol 6000 and Gelucire 44/14. Eur J
Pharm Sci. 2000; 10: 311-322.
Khan KA. The concept of dissolution efficiency.
J Pharm Pharmacol. 1975; 27: 48-49.
Biswal S, Sahoo J, Murthy PN, Giradkar RP,
Avari JG. Enhancement of Dissolution Rate of
Gliclazide Using Solid Dispersions with
Polyethylene Glycol 6000. AAPS PharmSciTech.
; 9(2): 563-570.
Asyarie S, Rachmawati H. In vivo and in vitro
evaluation of a solid dispersion system of
gliclazide: PEG 6000. PDA J Pharm Sci Technol.
; 61(5): 400- 410.
Perssutti B, Rubessa F, Princivalle F. Solid
dispersions of carbamazepine with gelucire 44/14
and 50/13. STP Pharm Sci. 2000; 10: 479-484.
